|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 477/20 | |
| A61K 31/40 | |||
| A61K 31/407 |
| (11) | Patento numeris | 1332145 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 01934937.2 |
| Europos patento paraiškos padavimo data | 2001-04-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2003-08-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2007-11-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2001/013794 |
| Data | 2001-04-27 |
| (87) | Numeris | WO 2002/034750 |
| Data | 2002-05-02 |
| (30) | Numeris | Data | Šalis |
| 698808 | 2000-10-27 | US | |
| PCT/US00/29869 | 2000-10-27 | WO |
| (72) |
AL-DEHNEH, Anthony, US
HUNKE, William, A., US
ILLIG, Kathleen, J., US
KANIKE, Anand, US
PATEL, Hiren, US
REYNOLDS, Scott, D., US
TSINONTIDES, Stelios, C., US
|
| (73) |
Merck & Co., Inc.,
126 East Lincoln Avenue, Rahway, New Jersey 07065-0907,
US
|
| (54) | PROCESS FOR FORMULATION OF ANTIBIOTIC COMPOUNDS |
| PROCESS FOR FORMULATION OF ANTIBIOTIC COMPOUNDS |